Hopp til hovedinnhold

Demens, atferdsforst. og psyk. sympt.

Sist revidert:
Sist revidert av:


  • Helsedirektoratet: Nasjonal faglig retningslinje om demens (magicapp.org), v3.1. Sist faglig oppdatert: 27. november 2019. https://helsedirektoratet.no/demens
  • Selbæk G. Atferdsforstyrrelser og psykiske symptomer ved demens. Tidskr Nor Legeforen 2005 Jun 2; 125(11): 1500-2. pmid:15940318
  1. Tible OP, Riese F, Savaskan E, von Gunten A.. Best practice in the management of behavioural and psychological symptoms of dementia. Ther Adv Neurol Disord 2017 Aug; 10(8): 297-309. pmid:28781611 PubMed  
  2. Helvik AS, Engedal K, Wu B, et al.. Severity of Neuropsychiatric Symptoms in Nursing Home Residents. Dement Geriatr Cogn Dis Extra 2016 Jan; 19;6(1): 28-42. pmid:26933438 PubMed  
  3. Lichtwarck B, Selbaek G, Kirkevold Ø, et al. TIME - Targeted interdisciplinary model for evaluation and treatment of neuropsychiatric symptoms: protocol for an effectiveness-implementation cluster randomized hybrid trial. BMC Psychiatry 2016 Jul . pmid:27406242 PubMed  
  4. Savva GM, Zaccai J, Matthews FE, et al.. Prevalence, correlates and course of behavioural and psychological symptoms of dementia in the population. Br J Psychiatry 2009 Mar; 194(3): 212-9. pmid:19252147 PubMed  
  5. Reese TR, Thiel DJ, Cocker KE. Behavioral disorders in dementia: appropriate nondrug interventions and antipsychotic use. Am Fam Physician. 2016 Aug 15;94(4):276-82. PMID: 27548592. PubMed  
  6. Lolk A, Gulmann NC. Psykofarmakologisk behandling af psykiatriske symptomer og adfærdsforstyrrelser ved demens. Ugeskr Læger 2006; 168: 3429-32. PubMed  
  7. Selbæk G. Atferdsforstyrrelser og psykiske symptomer ved demens. Tidskr Nor Legeforen 2005 Jun 2; 125(11): 1500-2. pmid:15940318 PubMed  
  8. Engtrø E, Nore SP, Kittang BR, Krüger K: Metodebok for sykehjemsleger. Bergen kommune. Første utgave, 2015. sykehjemshandboka.no  
  9. Shah C, DeMichele-Sweet MA, Sweet RA. Genetics of psychosis of Alzheimer disease. Am J Med Genet B Neuropsychiatr Genet 2017 Jan; 174(1): 27-35. pmid:26756273 PubMed  
  10. Helsedirektoratet. Nasjonal faglig retningslinje om demens. Sist faglig oppdatert: 03. januar 2020. helsedirektoratet.no  
  11. Watt JA, Goodarzi Z, Veroniki AA, et al. Comparative Efficacy of Interventions for Aggressive and Agitated Behaviors in Dementia: A Systematic Review and Network Meta-analysis. Ann Intern Med 2019; 171: 633-42. pmid:31610547 PubMed  
  12. Livingston G, Kelly L, Lewis-Holmes E, et al. Non-pharmacological interventions for agitation in dementia: systematic review of randomised controlled trials. BJPsych 2014. pmid: 25452601 PubMed  
  13. Chang YS, Chu H, Yang CY, et al. The efficacy of music therapy for people with dementia: A meta-analysis of randomised controlled trials. J Clin Nurs 2015. pmid: 26299594 PubMed  
  14. Forrester LT, Maayan N, Orrell M, et al. Aromatherapy for dementia. Cochrane Database of Syst Rev 2014; 2: CD003150. doi:10.1002/14651858.CD003150.pub2 DOI  
  15. Forbes D, Blake CM, Thiessen EJ, et al. Light therapy for improving cognition, activities of daily living, sleep, challenging behaviour, and psychiatric disturbances in dementia. Cochrane Database Syst Rev. 2014;2:CD003946. doi: 10.1002/14651858.CD003946.pub4. DOI  
  16. Helvik AS, Šaltytė Benth J, Wu B. Persistent use of psychotropic drugs in nursing home residents in Norway. BMC Geriatr 2017. pmid:28193181 PubMed  
  17. Husebo BS, Ballart C, Sandvik R, et. al. Efficacy of treating pain to reduce behavioural disturbances in residents of nursing homes with dementia: cluster randomised clinical trial. BMJ 2011; 343: d4065. BMJ (DOI)  
  18. Lolk A, Andersen K. Udredning og behandling af adfærdsforstyrrelser hos demente. Ugeskr Læger 2017; 179: 521-24. ugeskriftet.dk  
  19. Wang J, Yu JT, Wang HF. Pharmacological treatment of neuropsychiatric symptoms in Alzheimer's disease: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry 2015; 86(1): 101-9. pmid:24876182 PubMed  
  20. Dudas R, Malouf R, McCleery J, Dening T. Antidepressants for treating depression in dementia. Cochrane Database of Systematic Reviews 2018, Issue 8. Art. No.: CD003944. DOI: 10.1002/14651858.CD003944.pub2. DOI  
  21. Banerjee S, High J, Stirling S et al. Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial. Lancet. 2021 Oct 23;398(10310):1487-1497. PMID: 34688369 PubMed  
  22. Hartikainen S, Lonnroos E, Louhivuori K. Medication as a risk factor for falls: critical systematic review. J Gerontol A Biol Sci Med Sci. 2007. PMID: 17921433 PubMed  
  • Peter D. Jost, spesialist allmennmedisin, redaktør NEL